Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Note: animal studies indicate that high doses of DPP-4 inhibitors & GLP-1 agonists cause expansion of cells of the pancreatic ductal glands and can cause premalignant pancreatic intraepithelial lesions (PanIN) that have the potential to progress to pancreatic adenocarcinoma
Folic acid should be used with extreme caution in patients with undiagnosed anemia
We changed pharmacy vendor, now you cant get it unless you have had a history of diabetes. Senior Benefits Manager, large manufacturer Weve never offered it for weight loss, and it is still one of our top three prescriptions spends every year. HR Professional, large manufacturer We dont allow GLP-1s for weight loss In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs]. Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts
The FDA has required a boxed warning for semaglutide concerning the chance of thyroid C-cell tumors since semaglutide was approved on December 5, 2017.This FDA boxed warning advises patients concerning the link between semaglutide and the likelihood of thyroid c-cell tumors, which specifically includes medullary thyroid carcinoma (MTC)
US$ 25.15
US$ 25.25
US$ 29.55
US$ 23.75
US$ 25.58
US$ 25.43
US$ 27.31
